Search Results - "Rupnow, Marcia F.T."

Refine Results
  1. 1

    Characterization of Type 2 Diabetes Mellitus Burden by Age and Ethnic Groups Based on a Nationwide Survey by Lopez, Janice M.S., PharmD, MPH, Bailey, Robert A., MD, Rupnow, Marcia F.T., PhD, Annunziata, Kathy, MA

    Published in Clinical therapeutics (01-04-2014)
    “…Abstract Background Type 2 diabetes mellitus (T2DM) is the most common form of diabetes. Risk factors for its development include older age, obesity, family…”
    Get full text
    Journal Article
  2. 2

    Persistence with Migraine Prophylactic Treatment and Acute Migraine Medication Utilization in the Managed Care Setting by Yaldo, Avin Z., PhD, Wertz, Debra A., PharmD, Rupnow, Marcia F.T., PhD, Quimbo, Ralph M., MA

    Published in Clinical therapeutics (01-12-2008)
    “…Abstract Objective: The aim of this study was to describe persistence with migraine prophylactic treatment and acute migraine medication utilization in…”
    Get full text
    Journal Article
  3. 3

    Assessing and Managing All Aspects of Migraine: Migraine Attacks, Migraine-Related Functional Impairment, Common Comorbidities, and Quality of Life by Buse, Dawn C., PhD, Rupnow, Marcia F.T., PhD, Lipton, Richard B., MD

    Published in Mayo Clinic proceedings (2009)
    “…Migraine can be characterized as a chronic disorder with episodic attacks and the potential for progression to chronic migraine. We conducted a PubMed…”
    Get full text
    Journal Article
  4. 4

    Assessing and Managing All Aspects of Migraine: Migraine Attacks, Migraine-Related Functional Impairment, Common Comorbidities, and Quality of Life by Buse, Dawn C., Rupnow, Marcia F.T., Lipton, Richard B.

    Published in Mayo Clinic proceedings (01-05-2009)
    “…Migraine can be characterized as a chronic disorder with episodic attacks and the potential for progression to chronic migraine. We conducted a PubMed…”
    Get full text
    Journal Article
  5. 5

    Economic Burden of Transformed Migraine: Results From the American Migraine Prevalence and Prevention (AMPP) Study by Munakata, Julie, Hazard, Elisabeth, Serrano, Daniel, Klingman, David, Rupnow, Marcia F.T., Tierce, Jonothan, Reed, Michael, Lipton, Richard B.

    Published in Headache (01-04-2009)
    “…Objective.— To evaluate the impact of incident transformed migraine on health care resource utilization, medication use, and productivity loss. In addition,…”
    Get full text
    Journal Article
  6. 6

    Topiramate prescribing patterns among medicaid patients: Diagnosis, comorbidities, and dosing by Poston, Sara, PharmD, Dickson, Michael, PhD, Johnsrud, Michael, PhD, Rupnow, Marcia F.T., PhD, Gdovin, Joette M., PhD, MPA, Bramley, Thomas J., PhD, Armstrong, Robert B., MD

    Published in Clinical therapeutics (01-03-2007)
    “…Abstract Background: Routine clinical practice data are useful for payers and formulary decision makers to make sound decisions regarding coverage policy…”
    Get full text
    Journal Article
  7. 7

    Impact of hypoglycemia on patients with type 2 diabetes mellitus and their quality of life, work productivity, and medication adherence by Lopez, Janice Ms, Annunziata, Kathy, Bailey, Robert A, Rupnow, Marcia Ft, Morisky, Donald E

    Published in Patient preference and adherence (01-01-2014)
    “…The purpose of this study was to determine the characteristics of adults with type 2 diabetes mellitus (T2DM) that correlate with greater risk of hypoglycemia…”
    Get full text
    Journal Article
  8. 8

    The Burden of Migraine in the United States: Current and Emerging Perspectives on Disease Management and Economic Analysis by Hazard, Elisabeth, PhD, Munakata, Julie, MS, Bigal, Marcelo E., MD, PhD, Rupnow, Marcia F.T., PhD, Lipton, Richard B., MD

    Published in Value in health (2009)
    “…Abstract Objectives Migraine is often perceived as a low-impact condition that imposes a limited burden to society and the health-care system. This study…”
    Get full text
    Journal Article
  9. 9

    A dynamic transmission model for predicting trends in Helicobacter pylori and associated diseases in the United States by Rupnow, M F, Shachter, R D, Owens, D K, Parsonnet, J

    Published in Emerging infectious diseases (01-05-2000)
    “…To assess the benefits of intervention programs against Helicobacter pylori infection, we estimated the baseline curves of its incidence and prevalence. We…”
    Get full text
    Journal Article
  10. 10

    Diabetes-Related Composite Quality End Point Attainment: Canagliflozin Versus Sitagliptin Based on a Pooled Analysis of 2 Clinical Trials by Bailey, Robert A., MD, Vijapurkar, Ujjwala, PhD, Meininger, Gary, MD, Rupnow, Marcia F.T., PhD, Blonde, Lawrence, MD

    Published in Clinical therapeutics (01-05-2015)
    “…Abstract Purpose This post hoc analysis evaluated attainment of diabetes-related composite quality measures (CQMs) with canagliflozin 100 mg, canagliflozin 300…”
    Get full text
    Journal Article
  11. 11

    The Impact of Topiramate on Health-Related Quality of Life Indicators in Chronic Migraine by Dodick, David W., Silberstein, Stephen, Saper, Joel, Freitag, Fred G., Cady, Roger K., Rapoport, Alan M., Mathew, Ninan T., Hulihan, Joseph, Crivera, Concetta, Rupnow, Marcia F.T., Mao, Lian, Finlayson, Gary, Greenberg, Steven J.

    Published in Headache (01-11-2007)
    “…Background.— Chronic migraine is a disabling primary chronic daily headache disorder that significantly impacts the daily activities of patients with this…”
    Get full text
    Journal Article
  12. 12

    Potential drug–drug interactions with antiepileptic drugs in Medicaid recipients by Dickson, Michael, Bramley, Thomas J, Kozma, Chris, Doshi, Dilesh, Rupnow, Marcia F T

    Published in American journal of health-system pharmacy (15-09-2008)
    “…The frequency of potential drug-drug interactions (DDIs) between antiepileptic drugs (AEDs) and other (non-AED) medications in Medicaid patients taking newer…”
    Get full text
    Journal Article
  13. 13

    A taxonomy and economic consequences of nursing home falls by SORENSEN, Sonja V, DE LISSOVOY, Gregory, KUNAPRAYOON, Dan, RESNICK, Barbara, RUPNOW, Marcia F. T, STUDENSKI, Stephanie

    Published in Drugs & aging (01-01-2006)
    “…Falls are a primary cause of injury and disability in the nursing home environment and can be costly to treat. We propose a taxonomy of nursing home falls that…”
    Get full text
    Journal Article
  14. 14

    Cost-effectiveness model of long-acting risperidone in schizophrenia in the US by EDWARDS, Natalie C, RUPNOW, Marcia F. T, PASHOS, Chris L, BOTTEMAN, Marc F, DIAMOND, Ronald J

    Published in PharmacoEconomics (01-01-2005)
    “…Schizophrenia is a devastating and costly illness that affects 1% of the population in the US. Effective pharmacological therapies are available but suboptimal…”
    Get full text
    Journal Article
  15. 15

    Observed clinical and health services outcomes in pediatric inpatients treated with atypical antipsychotics: 1999-2003 by Flanders, Scott C, Findling, Robert L, Youngstrom, Eric A, Pandina, Gahan J, Rupnow, Marcia F T, Jensik, Sarah E, Carlson, Gabrielle A

    “…The aim of this study was to compare clinical and health services outcomes in pediatric inpatients prescribed an atypical antipsychotic (AA) to those not…”
    Get more information
    Journal Article
  16. 16

    Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients by Stokes, Michael E, Ye, Xin, Shah, Manan, Mercaldi, Katie, Reynolds, Matthew W, Rupnow, Marcia F T, Hammond, Jeffrey

    Published in BMC health services research (31-05-2011)
    “…Inadequate surgical hemostasis may lead to transfusion and/or other bleeding-related complications. This study examines the incidence and costs of…”
    Get full text
    Journal Article
  17. 17

    Indirect Cost Burden of Migraine in the United States by Hawkins, Kevin, Wang, Sara, Rupnow, Marcia F. T.

    “…Objective: The purpose of this study was to determine the indirect cost burden associated with migraine. Methods: Data were obtained from Thomson-Medstat's…”
    Get full text
    Journal Article
  18. 18

    Characteristics and short-term outcomes of patients with type 2 diabetes mellitus treated with canagliflozin in a real-world setting by Buysman, Erin K., Chow, Wing, Henk, Henry J., Rupnow, Marcia F.T.

    Published in Current medical research and opinion (01-01-2015)
    “…Abstract Objective: Canagliflozin is a sodium glucose co-transporter 2 inhibitor that has been shown to improve glycemic control in type 2 diabetes mellitus…”
    Get full text
    Journal Article
  19. 19

    Diabetes-related quality measure attainment: canagliflozin versus sitagliptin based on a pooled analysis of 2 clinical trials by Bailey, Robert A, Vijapurkar, Ujjwala, Meininger, Gary E, Rupnow, Marcia F T, Blonde, Lawrence

    Published in The American journal of managed care (01-12-2014)
    “…To evaluate attainment of diabetes-related quality measures with canagliflozin 100 mg, canagliflozin 300 mg, and sitagliptin 100 mg in patients with type 2…”
    Get full text
    Journal Article
  20. 20

    Validation of the Migraine-Specific Quality of Life Questionnaire Version 2.1 (Msq v. 2.1) for Patients Undergoing Prophylactic Migraine Treatment by Cole, Jason C., Lin, Peggy, Rupnow, Marcia F. T.

    Published in Quality of life research (01-09-2007)
    “…Objective Health-related quality of life (HRQoL) is an important outcome measure of migraine treatments. Although a number of migraine-specific HRQoL…”
    Get full text
    Journal Article